Sentences with phrase «in pediatric solid tumors»

11:00 AM Somatic mutations in pediatric solid tumors and identification of druggable pathways.

As an active researcher, much of her work is focused on regulation of angiogenesis in pediatric solid tumors, including Wilms» tumor, neuroblastoma, and hepatoblastoma.

Not exact matches

«This approval will open the floodgates for these kinds of therapy to be used in many different leukemias, lymphomas, solid tumors, myelomas,» Dr. Prakash Satwani, a pediatric hematologist - oncologist at Columbia University Medical Center, told Business Insider.

In fact, the Food and Drug Administration's approval of pembrolizumab in May 2017 for adult and pediatric patients with solid tumors and high microsatellite instability, was the first time it had approved a cancer treatment based on a genetic feature rather than the cancer's location of origiIn fact, the Food and Drug Administration's approval of pembrolizumab in May 2017 for adult and pediatric patients with solid tumors and high microsatellite instability, was the first time it had approved a cancer treatment based on a genetic feature rather than the cancer's location of origiin May 2017 for adult and pediatric patients with solid tumors and high microsatellite instability, was the first time it had approved a cancer treatment based on a genetic feature rather than the cancer's location of origin.

Because our team of pediatric specialists treats so many children with complex solid tumors, we are particularly well versed in the treatment of these conditions and have special expertise in even the most rare tumors.

We are also one of the nation's largest multidisciplinary programs caring for children with solid tumors, and have the largest pediatric oncology research effort in the state.

DATE: April 3 TIME: 4:05 p.m. LOCATION: Room 204, Level 2, Washington Convention Center TITLE: Comparison of somatic alterations in the genome and transcriptome of 1,705 pediatric leukemia and solid tumors: a report from the Children's Oncology Group (COG)- NCI TARGET Project ABSTRACT: 3004

A phase I / II trial of nivolumab (anti-PD-1) and low dose cyclophosphamide in progressive / relapsed pediatric solid tumors (NCT02901145).

Study 2, led by researchers in the U.S., analyzed the genomes and transcriptomes of 1,699 pediatric leukemias and solid tumors representing six histotypes.

The multikinase angiogenesis inhibitor pazopanib was well tolerated and exhibited some responses in pediatric patients with soft - tissue sarcomas and other refractory solid tumors in a phase I trial.